Non-GMO Feed
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Non-Invasive Prenatal Testing Devices Market Research Report 2023
1 Non-Invasive Prenatal Testing Devices Market Overview
1.1 Product Overview and Scope of Non-Invasive Prenatal Testing Devices
1.2 Non-Invasive Prenatal Testing Devices Segment by Type
1.2.1 Global Non-Invasive Prenatal Testing Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Ultrasound Devices
1.2.3 Next-Generation Sequencing Systems
1.2.4 Polymerase Chain Reaction Instruments
1.2.5 Microarrays
1.2.6 Other
1.3 Non-Invasive Prenatal Testing Devices Segment by Application
1.3.1 Global Non-Invasive Prenatal Testing Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Research Laboratories
1.4 Global Non-Invasive Prenatal Testing Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Prenatal Testing Devices Revenue 2017-2028
1.4.2 Global Non-Invasive Prenatal Testing Devices Sales 2017-2028
1.4.3 Non-Invasive Prenatal Testing Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Non-Invasive Prenatal Testing Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Prenatal Testing Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Non-Invasive Prenatal Testing Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Non-Invasive Prenatal Testing Devices Manufacturing Sites, Area Served, Product Type
2.5 Non-Invasive Prenatal Testing Devices Market Competitive Situation and Trends
2.5.1 Non-Invasive Prenatal Testing Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-Invasive Prenatal Testing Devices Players Market Share by Revenue
2.5.3 Global Non-Invasive Prenatal Testing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Prenatal Testing Devices Retrospective Market Scenario by Region
3.1 Global Non-Invasive Prenatal Testing Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Non-Invasive Prenatal Testing Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.3.1 North America Non-Invasive Prenatal Testing Devices Sales by Country
3.3.2 North America Non-Invasive Prenatal Testing Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.4.1 Europe Non-Invasive Prenatal Testing Devices Sales by Country
3.4.2 Europe Non-Invasive Prenatal Testing Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-Invasive Prenatal Testing Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Non-Invasive Prenatal Testing Devices Sales by Region
3.5.2 Asia Pacific Non-Invasive Prenatal Testing Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.6.1 Latin America Non-Invasive Prenatal Testing Devices Sales by Country
3.6.2 Latin America Non-Invasive Prenatal Testing Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-Invasive Prenatal Testing Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-Invasive Prenatal Testing Devices Sales by Country
3.7.2 Middle East and Africa Non-Invasive Prenatal Testing Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Non-Invasive Prenatal Testing Devices Historic Market Analysis by Type
4.1 Global Non-Invasive Prenatal Testing Devices Sales Market Share by Type (2017-2022)
4.2 Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Type (2017-2022)
4.3 Global Non-Invasive Prenatal Testing Devices Price by Type (2017-2022)
5 Global Non-Invasive Prenatal Testing Devices Historic Market Analysis by Application
5.1 Global Non-Invasive Prenatal Testing Devices Sales Market Share by Application (2017-2022)
5.2 Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Application (2017-2022)
5.3 Global Non-Invasive Prenatal Testing Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Philips
6.1.1 Philips Corporation Information
6.1.2 Philips Description and Business Overview
6.1.3 Philips Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Philips Non-Invasive Prenatal Testing Devices Product Portfolio
6.1.5 Philips Recent Developments/Updates
6.2 Illumina
6.2.1 Illumina Corporation Information
6.2.2 Illumina Description and Business Overview
6.2.3 Illumina Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Illumina Non-Invasive Prenatal Testing Devices Product Portfolio
6.2.5 Illumina Recent Developments/Updates
6.3 Thermo Fisher
6.3.1 Thermo Fisher Corporation Information
6.3.2 Thermo Fisher Description and Business Overview
6.3.3 Thermo Fisher Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Thermo Fisher Non-Invasive Prenatal Testing Devices Product Portfolio
6.3.5 Thermo Fisher Recent Developments/Updates
6.4 Beckman Coulter
6.4.1 Beckman Coulter Corporation Information
6.4.2 Beckman Coulter Description and Business Overview
6.4.3 Beckman Coulter Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Beckman Coulter Non-Invasive Prenatal Testing Devices Product Portfolio
6.4.5 Beckman Coulter Recent Developments/Updates
6.5 Pacific Biosciences
6.5.1 Pacific Biosciences Corporation Information
6.5.2 Pacific Biosciences Description and Business Overview
6.5.3 Pacific Biosciences Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Pacific Biosciences Non-Invasive Prenatal Testing Devices Product Portfolio
6.5.5 Pacific Biosciences Recent Developments/Updates
6.6 Oxford Nanopore
6.6.1 Oxford Nanopore Corporation Information
6.6.2 Oxford Nanopore Description and Business Overview
6.6.3 Oxford Nanopore Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Oxford Nanopore Non-Invasive Prenatal Testing Devices Product Portfolio
6.6.5 Oxford Nanopore Recent Developments/Updates
6.7 QIAGEN
6.6.1 QIAGEN Corporation Information
6.6.2 QIAGEN Description and Business Overview
6.6.3 QIAGEN Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 QIAGEN Non-Invasive Prenatal Testing Devices Product Portfolio
6.7.5 QIAGEN Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 GE Healthcare Non-Invasive Prenatal Testing Devices Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 BGI
6.9.1 BGI Corporation Information
6.9.2 BGI Description and Business Overview
6.9.3 BGI Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 BGI Non-Invasive Prenatal Testing Devices Product Portfolio
6.9.5 BGI Recent Developments/Updates
6.10 HYK Gene
6.10.1 HYK Gene Corporation Information
6.10.2 HYK Gene Description and Business Overview
6.10.3 HYK Gene Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 HYK Gene Non-Invasive Prenatal Testing Devices Product Portfolio
6.10.5 HYK Gene Recent Developments/Updates
6.11 Roche
6.11.1 Roche Corporation Information
6.11.2 Roche Non-Invasive Prenatal Testing Devices Description and Business Overview
6.11.3 Roche Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Roche Non-Invasive Prenatal Testing Devices Product Portfolio
6.11.5 Roche Recent Developments/Updates
6.12 Berry Genomics
6.12.1 Berry Genomics Corporation Information
6.12.2 Berry Genomics Non-Invasive Prenatal Testing Devices Description and Business Overview
6.12.3 Berry Genomics Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Berry Genomics Non-Invasive Prenatal Testing Devices Product Portfolio
6.12.5 Berry Genomics Recent Developments/Updates
6.13 CapitalBio
6.13.1 CapitalBio Corporation Information
6.13.2 CapitalBio Non-Invasive Prenatal Testing Devices Description and Business Overview
6.13.3 CapitalBio Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 CapitalBio Non-Invasive Prenatal Testing Devices Product Portfolio
6.13.5 CapitalBio Recent Developments/Updates
6.14 LabCorp
6.14.1 LabCorp Corporation Information
6.14.2 LabCorp Non-Invasive Prenatal Testing Devices Description and Business Overview
6.14.3 LabCorp Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 LabCorp Non-Invasive Prenatal Testing Devices Product Portfolio
6.14.5 LabCorp Recent Developments/Updates
6.15 LifeLabs Genetics
6.15.1 LifeLabs Genetics Corporation Information
6.15.2 LifeLabs Genetics Non-Invasive Prenatal Testing Devices Description and Business Overview
6.15.3 LifeLabs Genetics Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 LifeLabs Genetics Non-Invasive Prenatal Testing Devices Product Portfolio
6.15.5 LifeLabs Genetics Recent Developments/Updates
6.16 LifeCodexx
6.16.1 LifeCodexx Corporation Information
6.16.2 LifeCodexx Non-Invasive Prenatal Testing Devices Description and Business Overview
6.16.3 LifeCodexx Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 LifeCodexx Non-Invasive Prenatal Testing Devices Product Portfolio
6.16.5 LifeCodexx Recent Developments/Updates
6.17 Natera
6.17.1 Natera Corporation Information
6.17.2 Natera Non-Invasive Prenatal Testing Devices Description and Business Overview
6.17.3 Natera Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Natera Non-Invasive Prenatal Testing Devices Product Portfolio
6.17.5 Natera Recent Developments/Updates
6.18 Quest Diagnostics
6.18.1 Quest Diagnostics Corporation Information
6.18.2 Quest Diagnostics Non-Invasive Prenatal Testing Devices Description and Business Overview
6.18.3 Quest Diagnostics Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Quest Diagnostics Non-Invasive Prenatal Testing Devices Product Portfolio
6.18.5 Quest Diagnostics Recent Developments/Updates
6.19 Sequenom
6.19.1 Sequenom Corporation Information
6.19.2 Sequenom Non-Invasive Prenatal Testing Devices Description and Business Overview
6.19.3 Sequenom Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sequenom Non-Invasive Prenatal Testing Devices Product Portfolio
6.19.5 Sequenom Recent Developments/Updates
6.20 Genpharm Services
6.20.1 Genpharm Services Corporation Information
6.20.2 Genpharm Services Non-Invasive Prenatal Testing Devices Description and Business Overview
6.20.3 Genpharm Services Non-Invasive Prenatal Testing Devices Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Genpharm Services Non-Invasive Prenatal Testing Devices Product Portfolio
6.20.5 Genpharm Services Recent Developments/Updates
7 Non-Invasive Prenatal Testing Devices Manufacturing Cost Analysis
7.1 Non-Invasive Prenatal Testing Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-Invasive Prenatal Testing Devices
7.4 Non-Invasive Prenatal Testing Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-Invasive Prenatal Testing Devices Distributors List
8.3 Non-Invasive Prenatal Testing Devices Customers
9 Non-Invasive Prenatal Testing Devices Market Dynamics
9.1 Non-Invasive Prenatal Testing Devices Industry Trends
9.2 Non-Invasive Prenatal Testing Devices Market Drivers
9.3 Non-Invasive Prenatal Testing Devices Market Challenges
9.4 Non-Invasive Prenatal Testing Devices Market Restraints
10 Global Market Forecast
10.1 Non-Invasive Prenatal Testing Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-Invasive Prenatal Testing Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Non-Invasive Prenatal Testing Devices by Type (2023-2028)
10.2 Non-Invasive Prenatal Testing Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-Invasive Prenatal Testing Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Non-Invasive Prenatal Testing Devices by Application (2023-2028)
10.3 Non-Invasive Prenatal Testing Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-Invasive Prenatal Testing Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Non-Invasive Prenatal Testing Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-Invasive Prenatal Testing Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Non-Invasive Prenatal Testing Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Non-Invasive Prenatal Testing Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Non-Invasive Prenatal Testing Devices Market Competitive Situation by Manufacturers in 2021
Table 5. Global Non-Invasive Prenatal Testing Devices Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Non-Invasive Prenatal Testing Devices Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Non-Invasive Prenatal Testing Devices Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Non-Invasive Prenatal Testing Devices Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Non-Invasive Prenatal Testing Devices Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Non-Invasive Prenatal Testing Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Non-Invasive Prenatal Testing Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-Invasive Prenatal Testing Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Prenatal Testing Devices as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-Invasive Prenatal Testing Devices Sales by Region (2017-2022) & (K Units)
Table 16. Global Non-Invasive Prenatal Testing Devices Sales Market Share by Region (2017-2022)
Table 17. Global Non-Invasive Prenatal Testing Devices Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Region (2017-2022)
Table 19. North America Non-Invasive Prenatal Testing Devices Sales by Country (2017-2022) & (K Units)
Table 20. North America Non-Invasive Prenatal Testing Devices Sales Market Share by Country (2017-2022)
Table 21. North America Non-Invasive Prenatal Testing Devices Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Non-Invasive Prenatal Testing Devices Revenue Market Share by Country (2017-2022)
Table 23. Europe Non-Invasive Prenatal Testing Devices Sales by Country (2017-2022) & (K Units)
Table 24. Europe Non-Invasive Prenatal Testing Devices Sales Market Share by Country (2017-2022)
Table 25. Europe Non-Invasive Prenatal Testing Devices Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Non-Invasive Prenatal Testing Devices Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Non-Invasive Prenatal Testing Devices Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Non-Invasive Prenatal Testing Devices Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Non-Invasive Prenatal Testing Devices Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Non-Invasive Prenatal Testing Devices Revenue Market Share by Region (2017-2022)
Table 31. Latin America Non-Invasive Prenatal Testing Devices Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Non-Invasive Prenatal Testing Devices Sales Market Share by Country (2017-2022)
Table 33. Latin America Non-Invasive Prenatal Testing Devices Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Non-Invasive Prenatal Testing Devices Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Non-Invasive Prenatal Testing Devices Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Non-Invasive Prenatal Testing Devices Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Non-Invasive Prenatal Testing Devices Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Non-Invasive Prenatal Testing Devices Revenue Market Share by Country (2017-2022)
Table 39. Global Non-Invasive Prenatal Testing Devices Sales by Type (2017-2022) & (K Units)
Table 40. Global Non-Invasive Prenatal Testing Devices Sales Market Share by Type (2017-2022)
Table 41. Global Non-Invasive Prenatal Testing Devices Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Non-Invasive Prenatal Testing Devices Revenue Share by Type (2017-2022)
Table 43. Global Non-Invasive Prenatal Testing Devices Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Non-Invasive Prenatal Testing Devices Sales (K Units) by Application (2017-2022)
Table 45. Global Non-Invasive Prenatal Testing Devices Sales Market Share by Application (2017-2022)
Table 46. Global Non-Invasive Prenatal Testing Devices Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Non-Invasive Prenatal Testing Devices Revenue Share by Application (2017-2022)
Table 48. Global Non-Invasive Prenatal Testing Devices Price by Application (2017-2022) & (USD/Unit)
Table 49. Philips Corporation Information
Table 50. Philips Description and Business Overview
Table 51. Philips Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Philips Non-Invasive Prenatal Testing Devices Product
Table 53. Philips Recent Developments/Updates
Table 54. Illumina Corporation Information
Table 55. Illumina Description and Business Overview
Table 56. Illumina Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Illumina Non-Invasive Prenatal Testing Devices Product
Table 58. Illumina Recent Developments/Updates
Table 59. Thermo Fisher Corporation Information
Table 60. Thermo Fisher Description and Business Overview
Table 61. Thermo Fisher Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Thermo Fisher Non-Invasive Prenatal Testing Devices Product
Table 63. Thermo Fisher Recent Developments/Updates
Table 64. Beckman Coulter Corporation Information
Table 65. Beckman Coulter Description and Business Overview
Table 66. Beckman Coulter Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Beckman Coulter Non-Invasive Prenatal Testing Devices Product
Table 68. Beckman Coulter Recent Developments/Updates
Table 69. Pacific Biosciences Corporation Information
Table 70. Pacific Biosciences Description and Business Overview
Table 71. Pacific Biosciences Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Pacific Biosciences Non-Invasive Prenatal Testing Devices Product
Table 73. Pacific Biosciences Recent Developments/Updates
Table 74. Oxford Nanopore Corporation Information
Table 75. Oxford Nanopore Description and Business Overview
Table 76. Oxford Nanopore Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Oxford Nanopore Non-Invasive Prenatal Testing Devices Product
Table 78. Oxford Nanopore Recent Developments/Updates
Table 79. QIAGEN Corporation Information
Table 80. QIAGEN Description and Business Overview
Table 81. QIAGEN Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. QIAGEN Non-Invasive Prenatal Testing Devices Product
Table 83. QIAGEN Recent Developments/Updates
Table 84. GE Healthcare Corporation Information
Table 85. GE Healthcare Description and Business Overview
Table 86. GE Healthcare Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. GE Healthcare Non-Invasive Prenatal Testing Devices Product
Table 88. GE Healthcare Recent Developments/Updates
Table 89. BGI Corporation Information
Table 90. BGI Description and Business Overview
Table 91. BGI Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. BGI Non-Invasive Prenatal Testing Devices Product
Table 93. BGI Recent Developments/Updates
Table 94. HYK Gene Corporation Information
Table 95. HYK Gene Description and Business Overview
Table 96. HYK Gene Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. HYK Gene Non-Invasive Prenatal Testing Devices Product
Table 98. HYK Gene Recent Developments/Updates
Table 99. Roche Corporation Information
Table 100. Roche Description and Business Overview
Table 101. Roche Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Roche Non-Invasive Prenatal Testing Devices Product
Table 103. Roche Recent Developments/Updates
Table 104. Berry Genomics Corporation Information
Table 105. Berry Genomics Description and Business Overview
Table 106. Berry Genomics Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Berry Genomics Non-Invasive Prenatal Testing Devices Product
Table 108. Berry Genomics Recent Developments/Updates
Table 109. CapitalBio Corporation Information
Table 110. CapitalBio Description and Business Overview
Table 111. CapitalBio Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. CapitalBio Non-Invasive Prenatal Testing Devices Product
Table 113. CapitalBio Recent Developments/Updates
Table 114. LabCorp Corporation Information
Table 115. LabCorp Description and Business Overview
Table 116. LabCorp Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. LabCorp Non-Invasive Prenatal Testing Devices Product
Table 118. LabCorp Recent Developments/Updates
Table 119. LifeLabs Genetics Corporation Information
Table 120. LifeLabs Genetics Description and Business Overview
Table 121. LifeLabs Genetics Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. LifeLabs Genetics Non-Invasive Prenatal Testing Devices Product
Table 123. LifeLabs Genetics Recent Developments/Updates
Table 124. LifeCodexx Corporation Information
Table 125. LifeCodexx Description and Business Overview
Table 126. LifeCodexx Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. LifeCodexx Non-Invasive Prenatal Testing Devices Product
Table 128. LifeCodexx Recent Developments/Updates
Table 129. Natera Corporation Information
Table 130. Natera Description and Business Overview
Table 131. Natera Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Natera Non-Invasive Prenatal Testing Devices Product
Table 133. Natera Recent Developments/Updates
Table 134. Quest Diagnostics Corporation Information
Table 135. Quest Diagnostics Description and Business Overview
Table 136. Quest Diagnostics Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Quest Diagnostics Non-Invasive Prenatal Testing Devices Product
Table 138. Quest Diagnostics Recent Developments/Updates
Table 139. Sequenom Corporation Information
Table 140. Sequenom Description and Business Overview
Table 141. Sequenom Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Sequenom Non-Invasive Prenatal Testing Devices Product
Table 143. Sequenom Recent Developments/Updates
Table 144. Genpharm Services Corporation Information
Table 145. Genpharm Services Description and Business Overview
Table 146. Genpharm Services Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Genpharm Services Non-Invasive Prenatal Testing Devices Product
Table 148. Genpharm Services Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Non-Invasive Prenatal Testing Devices Distributors List
Table 152. Non-Invasive Prenatal Testing Devices Customers List
Table 153. Non-Invasive Prenatal Testing Devices Market Trends
Table 154. Non-Invasive Prenatal Testing Devices Market Drivers
Table 155. Non-Invasive Prenatal Testing Devices Market Challenges
Table 156. Non-Invasive Prenatal Testing Devices Market Restraints
Table 157. Global Non-Invasive Prenatal Testing Devices Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Non-Invasive Prenatal Testing Devices Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Non-Invasive Prenatal Testing Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Non-Invasive Prenatal Testing Devices Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Non-Invasive Prenatal Testing Devices Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Non-Invasive Prenatal Testing Devices Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Non-Invasive Prenatal Testing Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Non-Invasive Prenatal Testing Devices Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Non-Invasive Prenatal Testing Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Non-Invasive Prenatal Testing Devices Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Non-Invasive Prenatal Testing Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Non-Invasive Prenatal Testing Devices Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-Invasive Prenatal Testing Devices
Figure 2. Global Non-Invasive Prenatal Testing Devices Market Share by Type in 2021 & 2028
Figure 3. Ultrasound Devices Product Picture
Figure 4. Next-Generation Sequencing Systems Product Picture
Figure 5. Polymerase Chain Reaction Instruments Product Picture
Figure 6. Microarrays Product Picture
Figure 7. Other Product Picture
Figure 8. Global Non-Invasive Prenatal Testing Devices Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinics
Figure 11. Research Laboratories
Figure 12. Global Non-Invasive Prenatal Testing Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Non-Invasive Prenatal Testing Devices Market Size (2017-2028) & (US$ Million)
Figure 14. Global Non-Invasive Prenatal Testing Devices Sales (2017-2028) & (K Units)
Figure 15. Non-Invasive Prenatal Testing Devices Sales Share by Manufacturers in 2021
Figure 16. Global Non-Invasive Prenatal Testing Devices Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Non-Invasive Prenatal Testing Devices Players: Market Share by Revenue in 2021
Figure 18. Non-Invasive Prenatal Testing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Non-Invasive Prenatal Testing Devices Sales Market Share by Region (2017-2022)
Figure 20. Global Non-Invasive Prenatal Testing Devices Sales Market Share by Region in 2021
Figure 21. Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Region (2017-2022)
Figure 22. Global Non-Invasive Prenatal Testing Devices Revenue Market Share by Region in 2021
Figure 23. U.S. Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Non-Invasive Prenatal Testing Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Non-Invasive Prenatal Testing Devices by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Non-Invasive Prenatal Testing Devices
Figure 49. Manufacturing Process Analysis of Non-Invasive Prenatal Testing Devices
Figure 50. Non-Invasive Prenatal Testing Devices Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Philips Illumina Thermo Fisher Beckman Coulter Pacific Biosciences Oxford Nanopore QIAGEN GE Healthcare BGI HYK Gene Roche Berry Genomics CapitalBio LabCorp LifeLabs Genetics LifeCodexx Natera Quest Diagnostics Sequenom Genpharm Services